Application of LARS Ligament in Bone Prosthesis Replacement

Launched by HENAN CANCER HOSPITAL · Nov 14, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how a special type of ligament called the LARS ligament can improve outcomes for patients who have undergone surgery to replace bone due to malignant tumors, which are cancerous growths. The trial will compare two groups of patients: one group will receive the LARS ligament along with their bone prosthesis (an artificial bone), while the other group will only receive the bone prosthesis. Researchers will gather information on how well each group does after surgery, including any complications and how well they can use their limbs.

Anyone can participate in the trial as long as they are diagnosed with a type of malignant tumor and are treated at the hospital where the study is taking place. There are no age restrictions, and both men and women are welcome. If you join the trial, you can expect to have your health and recovery closely monitored, which will help researchers understand the benefits of using the LARS ligament in surgery. It's important to note that the trial is not yet recruiting participants, but it is designed to provide valuable insights into improving care for people with cancer-related bone issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women of all ages are welcome.
• • Pathologically confirmed in our hospital as a subtype of malignant tumor.
• • He received LARS ligament and bone prosthesis replacement at our hospital.
• Exclusion Criteria:
• • Not Applicable.